Campylobacter infection
- Overview
- Theory
- Diagnosis
- Management
- Follow up
- Resources
Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
gastroenteritis
fluid replacement therapy
The most common complication of diarrhoeal illnesses is dehydration. Initial treatment in every patient with Campylobacterinfection begins with hydration.[14]Centers for Disease Control and Prevention. CDC Yellow Book 2024: traveler's health. Section 5: travel-associated infections & diseases - campylobacteriosis. May 2023 [internet publication]. https://wwwnc.cdc.gov/travel/yellowbook/2024/infections-diseases/campylobacteriosis
For patients who can take oral liquid, rehydration with increased fluids or oral rehydration solutions (ORS) - consisting of water, sugars, and electrolytes - are recommended. One systematic review found polymer-based ORS had advantages over glucose-based ORS, but the analysis was underpowered.[40]Gregorio GV, Gonzales ML, Dans LF, Martinez EG. Polymer-based oral rehydration solution for treating acute watery diarrhoea. Cochrane Database Syst Rev. 2016 Dec 13;12(12):CD006519. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006519.pub3/full http://www.ncbi.nlm.nih.gov/pubmed/27959472?tool=bestpractice.com For those unable to tolerate oral fluids due to nausea and vomiting, intravenous fluids should be administered, and the electrolyte balance monitored closely.
antibiotics
Additional treatment recommended for SOME patients in selected patient group
Antibiotics are not indicated in uncomplicated cases.[14]Centers for Disease Control and Prevention. CDC Yellow Book 2024: traveler's health. Section 5: travel-associated infections & diseases - campylobacteriosis. May 2023 [internet publication]. https://wwwnc.cdc.gov/travel/yellowbook/2024/infections-diseases/campylobacteriosis [41]Ternhag A, Asikainen T, Giesecke J, et al. A meta-analysis on the effects of antibiotic treatment on duration of symptoms caused by infection with Campylobacter species. Clin Infect Dis. 2007 Mar 1;44(5):696-700. http://www.ncbi.nlm.nih.gov/pubmed/17278062?tool=bestpractice.com
Indications for antimicrobial therapy include high fever, systemic infection with suspected or sustained bacteraemia, grossly bloody diarrhoea, and persistence of symptoms for >1 week. Antibiotics are also indicated in immunocompromised patients.
Macrolides (e.g., azithromycin, erythromycin) are generally the treatment of choice in both children and adults.[28]Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017 Nov 29;65(12):e45-80. https://academic.oup.com/cid/article/65/12/e45/4557073 http://www.ncbi.nlm.nih.gov/pubmed/29053792?tool=bestpractice.com [42]Riddle MS, DuPont HL, Connor BA. ACG clinical guideline: diagnosis, treatment, and prevention of acute diarrheal infections in adults. Am J Gastroenterol. 2016 May;111(5):602-22. https://gi.org/guideline/diagnosis-treatment-and-prevention-of-acute-diarrheal-infections-in-adults/ http://www.ncbi.nlm.nih.gov/pubmed/27068718?tool=bestpractice.com Azithromycin is the preferred macrolide due to the convenience of single dosing. Erythromycin is used less commonly, but is the recommended drug in pregnancy.[43]World Gastroenterology Organisation (WGO). WGO practice guideline: acute diarrhea. 2012 [internet publication]. https://www.worldgastroenterology.org/assets/export/userfiles/Acute%20Diarrhea_long_FINAL_120604.pdf Macrolides may cause QT interval prolongation. Use caution in: patients with a history of QT interval prolongation; conditions that may increase the risk of QT prolongation or torsades de pointes; or patients who are on other medications known to prolong the QT interval.
Fluoroquinolones (e.g., ciprofloxacin) are only recommended when it is considered inappropriate to use other antibiotics that are commonly recommended for this infection. Systemic fluoroquinolone antibiotics may cause serious, disabling, and potentially long-lasting or irreversible adverse events. This includes, but is not limited to: tendinopathy/tendon rupture; peripheral neuropathy; arthropathy/arthralgia; aortic aneurysm and dissection; heart valve regurgitation; dysglycaemia; and central nervous system effects including seizures, depression, psychosis, and suicidal thoughts and behaviour.[44]Rusu A, Munteanu AC, Arbănași EM, et al. Overview of side-effects of antibacterial fluoroquinolones: new drugs versus old drugs, a step forward in the safety profile? Pharmaceutics. 2023 Mar 1;15(3):804. https://www.mdpi.com/1999-4923/15/3/804 http://www.ncbi.nlm.nih.gov/pubmed/36986665?tool=bestpractice.com Prescribing restrictions apply to the use of fluoroquinolones, and these restrictions may vary between countries. In general, fluoroquinolones should be restricted for use in serious, life-threatening bacterial infections only. Some regulatory agencies may also recommend that they must only be used in situations where other antibiotics, that are commonly recommended for the infection, are inappropriate (e.g., resistance, contraindications, treatment failure, and unavailability). Consult your local guidelines and drug formulary for more information on suitability, contraindications, and precautions.
Research by the Centers for Disease Control and Prevention indicates that antibiotic-resistant strains of Campylobacter have increased. In 2019, 28% of Campylobacter infections were resistant to ciprofloxacin and 4% were resistant to azithromycin, with 2% having decreased susceptibility to both medicines.[45]Centers for Disease Control and Prevention. Antibiotic/antimicrobial resistance (AR/AMR). Nov 2021 [internet publication]. https://www.cdc.gov/drugresistance/biggest-threats.html
In immunocompromised patients, antimicrobial therapy should be chosen based on laboratory sensitivity testing, and prolonged therapy is usually necessary.[46]Schiaffino F, Kosek MN. Intestinal and extra-intestinal manifestations of Campylobacter in the immunocompromised host. Curr Treat Options Infect Dis. 2020;12(4):361-74.[47]Roa-Bautista A, Brown LK, Tadros S, et al. Clinical features, immunological characteristics, and treatment outcomes of Campylobacter spp. infections in patients with common variable immunodeficiency. J Allergy Clin Immunol Pract. 2023 Nov;11(11):3493-501.e4. https://www.jaci-inpractice.org/article/S2213-2198(23)00715-8/fulltext http://www.ncbi.nlm.nih.gov/pubmed/37406804?tool=bestpractice.com
In complicated cases requiring the use of antibiotics, empirical treatment should begin while waiting for sensitivity testing.
With systemic infections, intravenous antibiotics are indicated.
If a patient does not respond to sensitivity-guided antimicrobial therapy, other possible aetiologies should be investigated.
Treatment course: 5 days (erythromycin, ciprofloxacin); 3-5 days (azithromycin).[42]Riddle MS, DuPont HL, Connor BA. ACG clinical guideline: diagnosis, treatment, and prevention of acute diarrheal infections in adults. Am J Gastroenterol. 2016 May;111(5):602-22. https://gi.org/guideline/diagnosis-treatment-and-prevention-of-acute-diarrheal-infections-in-adults/ http://www.ncbi.nlm.nih.gov/pubmed/27068718?tool=bestpractice.com [43]World Gastroenterology Organisation (WGO). WGO practice guideline: acute diarrhea. 2012 [internet publication]. https://www.worldgastroenterology.org/assets/export/userfiles/Acute%20Diarrhea_long_FINAL_120604.pdf
Primary options
azithromycin: children: 10 mg/kg orally once daily, maximum 500 mg/day; adults: 500 mg orally once daily
OR
erythromycin base: children: 30-50 mg/kg/day orally given in 4 divided doses, maximum 2000mg/day; adults: 500 mg orally four times daily
Secondary options
ciprofloxacin: adults: 500-750 mg orally twice daily
probiotics
Additional treatment recommended for SOME patients in selected patient group
Probiotics can be offered to reduce the symptom severity and duration of diarrhoea in immunocompetent adults and children with infectious or antimicrobial-associated diarrhoea.[28]Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017 Nov 29;65(12):e45-80. https://academic.oup.com/cid/article/65/12/e45/4557073 http://www.ncbi.nlm.nih.gov/pubmed/29053792?tool=bestpractice.com However, additional research is needed to guide the use of probiotics in patients suffering from Campylobacterenteritis.[48]Collinson S, Deans A, Padua-Zamora A, et al. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev. 2020 Dec 8;12(12):CD003048. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003048.pub4/full http://www.ncbi.nlm.nih.gov/pubmed/33295643?tool=bestpractice.com
zinc
Additional treatment recommended for SOME patients in selected patient group
Oral zinc supplementation has been shown to reduce the duration of infectious diarrhoea in children aged 6 months to 5 years in countries with a high prevalence of zinc deficiency or in children suffering from malnutrition.[28]Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017 Nov 29;65(12):e45-80. https://academic.oup.com/cid/article/65/12/e45/4557073 http://www.ncbi.nlm.nih.gov/pubmed/29053792?tool=bestpractice.com
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer